Corcept Therapeutics Inc. buy StockNews.com
Start price
17.02.24
/
50%
€21.00
Target price
17.02.25
-
Performance (%)
233.43%
End price
18.02.25
€70.02
Summary
This prediction ended on 18.02.25 with a price of €70.02. With a performance of 233.43% the BUY prediction by StockNews_com was a big success. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Corcept Therapeutics Inc. | -3.169% | -3.169% | -42.982% |
| iShares Core DAX® | -5,87 % | -2,50 % | 2,29 % |
| iShares Nasdaq 100 | 1,66 % | 3,51 % | 13,19 % |
| iShares Nikkei 225® | -6,13 % | 2,14 % | 27,67 % |
| iShares S&P 500 | 0,50 % | 2,05 % | 9,82 % |
Comments by StockNews_com for this prediction
In the thread Corcept Therapeutics Inc. diskutieren
Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for CORT provided by MarketBeat
In the thread Trading Corcept Therapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Corcept Therapeutics Inc.
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€21.38
18.04.24
18.04.24
-
18.04.25
18.04.25
153.04%
19.04.25
19.04.25
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€20.60
24.02.24
24.02.24
-
24.02.25
24.02.25
183.79%
25.02.25
25.02.25